OHARA Pharmaceutical Co.,Ltd.

Entirely from the patients' perspective Providing dependable pharmaceuticals for the future of medicine Ohara Pharmaceutical Co.,Ltd.

February 15, 2019: License Agreement on Novel Gliomas Treatment (PDF: 123KB)
December 20, 2018: Novel development drug OP-724 (PRI-724) for the treatment of cirrhosis is published on Nature Outline (PDF: 152KB)
November 14, 2018: A development project for a novel therapeutic agent for liver cirrhosis was adopted as the Cyclic Innovation for Clinical Innovation for Clinical Empowerment(CiCLE) by the Japan Agency for Medical Research and Development(AMED) (PDF: 188KB)
June 21, 2018: Ohara has entered into license agreement with PRISM on novel liver cirrhosis treatment (PDF: 116KB)
September 13, 2017: A Cooperative Research Study with the National Cancer Center Japan (PDF: 1.03MB)